Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA approves low-dose Estratab for osteoporosis

March 13, 1998

Risedronate: a potential nonhormonal agent for the prevention of osteoporosis

March 13, 1998

Alendronate sodium: a promising therapeutic agent for the prophylaxis of postmenopausal bone loss

March 13, 1998

New testosterone replacement patch launched in U.S.

March 12, 1998

Merck investigates antidiabetic/antiobesity agents

March 12, 1998

U.S. patent awarded for Sertoli cell transplants

March 12, 1998

Bone Care International submits NDA for oral one-alpha D2

March 11, 1998

Polydex receives continuing funding for contraceptive research

March 11, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Lilly expands product options for Ligand

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...